We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$504B
AUM Growth
+$32.2B
Cap. Flow
+$5.9B
Cap. Flow %
1.17%
Top 10 Hldgs %
18.16%
Holding
6,959
New
774
Increased
2,659
Reduced
2,316
Closed
526

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Consumer Discretionary 9%
3 Financials 7.65%
4 Healthcare 7.34%
5 Communication Services 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
6076
DELISTED
OptiNose
OPTN
$90K ﹤0.01%
3,688
+1,676
+83% +$56.1K
VIOT
6077
Viomi Technology
VIOT
$50.7M
$90K ﹤0.01%
37,338
+3,745
+11% +$14.3K
VYGR icon
6078
Voyager Therapeutics
VYGR
$187M
$90K ﹤0.01%
33,283
-22,664
-41% -$77.3K
CAPR icon
6079
Capricor Therapeutics
CAPR
$228M
$89K ﹤0.01%
30,417
+8,279
+37% +$29K
LQDA icon
6080
Liquidia Corp
LQDA
$7.93B
$89K ﹤0.01%
18,240
+2,557
+16% +$10.2K
LFMD icon
6081
LifeMD
LFMD
$178M
$88K ﹤0.01%
+22,789
New +$108K
GTX icon
6082
Garrett Motion
GTX
$5.86B
$87K ﹤0.01%
10,890
-6,996
-39% -$51.6K
XNET
6083
Xunlei
XNET
$327M
$87K ﹤0.01%
43,470
+11,106
+34% +$29.1K
ABVEW
6084
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$87K ﹤0.01%
168,645
LABP
6085
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$84K ﹤0.01%
+1,757
New +$185K
CADL icon
6086
Candel Therapeutics
CADL
$766M
$83K ﹤0.01%
+10,593
New +$103K
LVO icon
6087
LiveOne
LVO
$57.2M
$83K ﹤0.01%
6,464
-3,776
-37% -$82.7K
ZYNE
6088
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$83K ﹤0.01%
28,671
-35,797
-56% -$132K
BGSX.WS
6089
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$83K ﹤0.01%
119,909
SPAQ.WS
6090
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$83K ﹤0.01%
57,572
RCON icon
6091
Recon Technology
RCON
$5.76M
$82K ﹤0.01%
+3,497
New +$129K
UONEK icon
6092
Urban One Class D
UONEK
$24.3M
$82K ﹤0.01%
+2,409
New +$118K
PHYT.WS
6093
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$82K ﹤0.01%
+145,200
New +$82.2K
ZVIA icon
6094
Zevia
ZVIA
$123M
$80K ﹤0.01%
+11,393
New +$111K
ASAXW
6095
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$80K ﹤0.01%
156,671
SCOAW
6096
DELISTED
ScION Tech Growth I Warrant
SCOAW
$80K ﹤0.01%
133,333
MIST icon
6097
Milestone Pharmaceuticals
MIST
$143M
$79K ﹤0.01%
12,004
ODT
6098
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$79K ﹤0.01%
58,210
+12,050
+26% +$28.5K
MBII
6099
DELISTED
Marrone Bio Innovations, Inc.
MBII
$78K ﹤0.01%
108,378
+69,108
+176% +$55.9K
HMPT
6100
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$77K ﹤0.01%
17,068
-43,245
-72% -$185K

Similar funds

Goldman Sachs's Q4 2021 Portfolio in Review

As of Q4 2021, Goldman Sachs held 6,959 positions worth $504B, up 6.8% from $471B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q4 2021 filing shows 774 new, 2,659 increased, 2,316 reduced and 526 closed positions. Its largest new stake was Mirion Technologies: 53,265,743 shares worth $558M. The largest sale was Alibaba, an estimated $1.21B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Goldman Sachs's largest Q4 2021 buy was Mirion Technologies: 53,265,743 shares worth $558M.
  • Goldman Sachs added most to Invesco QQQ Trust in Q4 2021, an estimated $1.73B increase.
  • Goldman Sachs's biggest Q4 2021 reduction was Alibaba, cutting an estimated $1.21B.
  • Goldman Sachs fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $277M.
  • Goldman Sachs's ten largest holdings make up 18% of its $504B portfolio in Q4 2021.
  • Goldman Sachs opened 774 new positions and closed 526 in Q4 2021.
  • Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $504B.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.